Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00623363 · ClinicalTrials.gov registry record · Phase 2

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 2
Development phase
27
Enrollment target
7
Study locations

NCT00623363 is a Phase 2 study of Parkinson's Disease that has completed, run by Daiichi Sankyo. The registered enrollment target is 27 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00623363, a Phase 2 study of Parkinson's Disease, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 2
Development phase
27 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.

Conditions Studied

Parkinson's Disease

Interventions

  • DRUG piclozotan
  • DRUG 0.9% sodium chloride (normal saline)

Study Locations (7)

Other

  • Hospital Multimedica - Guatemala City
  • Hospital Clinic of Neurology and Psychiatry Oradea - Oradea

California

  • The Parkinson's and Movement Disorder Institute - Fountain Valley

Florida

  • University of South Florida, Parkinson's Disease and Movement Disorders Center - Tampa

Georgia

  • Emory University--Wesley Woods Health Center - Atlanta

New Jersey

  • UMDNJ-Robert Wood Johnson Medical School - New Brunswick

New York

  • Suny Downstate Medical Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2007-07-13
Est. Completion 2008-07-17
Phase Phase 2

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00623363

The ClinicalTrials.gov registry entry for NCT00623363 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which piclozotan is the first listed.

NCT00623363 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00623363 about?

NCT00623363 is a clinical study titled "Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease". The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.

What is the current status of trial NCT00623363?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2007-07-13. Estimated completion is 2008-07-17.

What conditions does trial NCT00623363 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00623363?

The interventions under investigation include: piclozotan (DRUG), 0.9% sodium chloride (normal saline) (DRUG).

Who is sponsoring clinical trial NCT00623363?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00623363 being conducted?

This trial has 7 study locations across California, Florida, Georgia, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.